Inventor
REVEL MICHEL
IL40 patents
⚠️ This page may combine multiple inventors who share the name “REVEL MICHEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
YEDA RES & DEV
33 patentsUS5468609ANov 21, 1995
Production of interferon
YEDA RES & DEV92 citations97
US5618700AApr 8, 1997
IL-6 specific monoclonal antibodies, hybridomas therefor and methods of making and using same
YEDA RES & DEV113 citations96
US5541312AJul 30, 1996
Production of interferon
YEDA RES & DEV67 citations96
US5468607ANov 21, 1995
Production of interferon
YEDA RES & DEV67 citations96
US5468608ANov 21, 1995
Production of interferon
YEDA RES & DEV66 citations96
US5621077AApr 15, 1997
Soluble IFN-β2/IL-6 binding protein its preparation, and pharmaceutical compositions containing it
YEDA RES & DEV90 citations95
US5554513ASep 10, 1996
Production of recombinant human interferon-beta2
YEDA RES & DEV97 citations95
US5216128AJun 1, 1993
IFN-β2/IL-6 receptor its preparation and pharmaceutical compositions containing it
YEDA RES & DEV55 citations95
US4808523AFeb 28, 1989
Constitutive production of human IFN-β1 by mammalian cells transformed by the IFN-β1 gene fused to an SV40 early promoter
YEDA RES & DEV25 citations92
US4889803ADec 26, 1989
Production of interferon gamma
YEDA RES & DEV53 citations89
US4898891AFeb 6, 1990
Antiviral compositions
YEDA RES & DEV46 citations88
US7198781B1Apr 3, 2007
Chimeric interleukin-6 soluble receptor/ligand proteins
YEDA RES & DEV12 citations82
US5510472AApr 23, 1996
Production of recombinant human interferon-beta2
YEDA RES & DEV15 citations74
US4622292ANov 11, 1986
Assay and kit for determining interferon
YEDA RES & DEV11 citations74
US5902576AMay 11, 1999
Antitumor pharmaceutical composition comprising IL-6 transfected cells
YEDA RES & DEV6 citations72
US5763210AJun 9, 1998
Recombinant production of interferon-gamma binding proteins
YEDA RES & DEV13 citations72
US5049589ASep 17, 1991
Antiviral aerosol compositions and pressurized containers containing same
YEDA RES & DEV8 citations71
US6172042B1Jan 9, 2001
Synthetic peptides that inhibit IL-6 activity
YEDA RES & DEV11 citations68
US5643749AJul 1, 1997
Soluble interferon α-receptor, its preparation and use
YEDA RES & DEV7 citations66
US4378352AMar 29, 1983
(2'-5')Oligo-isoadenylate pharmaceutical compositions and method of use
YEDA RES & DEV12 citations66
US5554514ASep 10, 1996
Production of recombinant human interferon beta2.sbsb.B
YEDA RES & DEV3 citations62
US5071963ADec 10, 1991
Interferon-induced human (2'-5') oligo a synthetase
YEDA RES & DEV4 citations62
US5063159ANov 5, 1991
Interferon-induced (2'-5') oligo a synthetase gene, mRNA, cDNA and enzymes having (2'-5') oligo a synthetase activity
YEDA RES & DEV5 citations62
US11406670B2Aug 9, 2022
Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS
YEDA RES & DEV0 citations59
US7824670B2Nov 2, 2010
Use of il6r/il6 chimera in nerve cell regeneration
YEDA RES & DEV5 citations58
US5462731AOct 31, 1995
Use of IL-6 for the treatment of chronic lymphocyte leukemia (CLL) and B-cell lymphomas
YEDA RES & DEV4 citations58
US4302533ANov 24, 1981
Novel assays for interferon
YEDA RES & DEV5 citations58
US7264945B2Sep 4, 2007
IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons
YEDA RES & DEV2 citations53
US7374912B2May 20, 2008
Nucleic acids encoding chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof
YEDA RES & DEV1 citations50
US10258651B2Apr 16, 2019
Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS
YEDA RES & DEV0 citations49
US9631175B2Apr 25, 2017
Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS
YEDA RES & DEV0 citations49
US7524928B2Apr 28, 2009
IFN receptor 1 binding proteins
YEDA RES & DEV0 citations43
US5358867AOct 25, 1994
DNA cloning and expression of an L7 protein which modulates the 2'-5' oligosynthetase and H2-K*K response to type-I interferon
YEDA RES & DEV1 citations42
REVEL MICHEL
4 patentsUS8809052B2Aug 19, 2014
Methods of generating mature oligodendrocytes
REVEL MICHEL5 citations79
US9404087B2Aug 2, 2016
Insulin producing cells derived from pluripotent stem cells
REVEL MICHEL4 citations66
US8617887B2Dec 31, 2013
Method of generating oligodendrocytes from neurosphere cells
REVEL MICHEL0 citations44
US8394367B2Mar 12, 2013
IL6R/IL6 chimera for therapy of chemotherapy-induced peripheral neuropathy
REVEL MICHEL1 citations44